Italia markets closed

ILMN May 2024 125.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,0300-3,8700 (-99,23%)
In data: 03:38PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente3,9000
Aperto4,7000
Denaro0,0000
Lettera0,0500
Prezzo d'esercizio125,00
Scadenza2024-05-03
Min-Max giorno0,0300 - 1,8700
Contratto - Min-MaxN/D
Volume19
Open Interest156
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera